Category: Healthcare

The global Preterm Birth and PROM Testing Market is projected to witness significant growth, driven by increasing preterm birth rates and advancements in diagnostic testing. In 2025, the market is estimated to be valued at USD 2.9 Billion, up from USD 2.8 Billion in 2024. With a 4.2% CAGR

The global preterm birth diagnostic test kits market is projected to grow from USD 153.2 million in 2025 to USD 417.5 million by 2035, registering a CAGR of 8.6%

The global preterm birth prevention and management market is projected to reach USD 2.70 billion in 2025, growing at an accelerated rate as healthcare advancements continue to improve neonatal care. By 2035, the market valuation is expected to exceed USD 5.49 billion, with a CAGR of 11.2%

The global preventive medicine market is projected to witness significant growth, reaching USD 897.59 billion by 2035, up from USD 397.63 billion in 2025, at a CAGR of 9.4%

The Primary Hyperoxaluria Treatment Market is witnessing rapid advancements, driven by increasing prevalence and innovative treatment options. In 2025, the market is expected to be valued at USD 19 million, up from USD 18 million in 2024. With an estimated 9.6% CAGR

The global Primary Sclerosing Cholangitis (PSC) market is expected to experience steady growth, reaching USD 315.26 million by 2035, up from USD 152.07 million in 2025, at a CAGR of 8.6%.

The Prinzmetal Angina Therapeutics Market is witnessing significant expansion, fueled by the rising prevalence of ischemic heart diseases and continuous advancements in drug development. The market is projected to be valued at USD 11.7 billion in 2025, with an anticipated CAGR of 5.85%

The global procalcitonin (PCT) assay market is anticipated to witness substantial growth, reaching US$ 513.9 million by 2035, up from US$ 281.6 million in 2025, at a CAGR of 7.2%. The increasing prevalence of bacterial infections, advancements in diagnostic technology, and heightened awareness of sepsis management are key drivers of this growth.

The Progesterone Market is poised for remarkable growth, driven by rising demand for hormone-based therapies, increasing awareness about reproductive health, and advancements in pharmaceutical formulations. The market is projected to reach US$ 2.5 billion in 2025, growing at a CAGR of 13.3%, and is anticipated to achieve a valuation of US$ 5.8 billion by 2035.

The global Progressive Fibrosing Interstitial Lung Disease (PFILD) treatment market is projected to grow significantly, reaching US$ 9.65 billion by 2035, up from US$ 5.74 billion in 2025, at a CAGR of 7.2%. The increasing prevalence of interstitial lung diseases, advancements in drug development, and growing awareness of PFILD are key drivers of this market…